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Feasibility study of computed tomography
colonography using limited bowel preparation
at normal and low-dose levels study
Abstract The purposewas to evaluate
low-dose CT colonography without
cathartic cleansing in terms of image
quality, polyp visualization and patient
acceptance. Sixty-one patients sched-
uledforcolonoscopystartedalow-fiber
diet,lactuloseandamidotrizoic-acidfor
fecaltagging2dayspriortotheCTscan
(standard dose, 5.8–8.2 mSv). The
original raw data of 51 patients were
modified and reconstructed at simu-
lated 2.3 and 0.7 mSv levels. Two
observers evaluated the standard dose
scan regarding image quality and
polyps. A third evaluated the presence
of polyps at all three mSv levels in a
blinded prospective way. All observers
were blinded to the reference standard:
colonoscopy. At three times patients
were given questionnaires relating to
theirexperiencesandpreference.Image
qualitywassufficientinallpatients,but
significantly lower in the cecum, sig-
moid and rectum. The two observers
correctly identified respectively 10/15
(67%) and 9/15 (60%) polyps ≥10mm,
with 5 and 8 false-positive lesions
(standard dose scan). Dose reduction
down to 0.7 mSv was not associated
with significant changes in diagnostic
value (polyps ≥10 mm). Eighty percent
of patients preferred CT colonography
and 13% preferred colonoscopy
(P<0.001). CTcolonography without
cleansing is preferred to colonoscopy
and shows sufficient image quality and
moderate sensitivity, without impaired
diagnostic value at dose-levels as low
as 0.7 mSv.
Keywords CT colonography .
Fecal tagging . Colonic neoplasm .
Colonoscopy
Abbreviations CTC: computed
tomography colonography .
CC: conventional colonoscopy
Introduction
Since computed tomography colonography (CTC) has
shown good results in detecting clinically relevant polyps
[1–6], studies have been performed focusing on increasing
patient acceptance by reducing the bowel preparation. This
can be done by adding an oral contrast agent to meals (fecal
tagging) [7–12] in combination with a low-fiber diet, and
sometimes lactulose for stool softening, thereby obviating
extensive cleansing.
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However, only a limited number of these studies on CTC
have used limited bowel preparation. Few have evaluated
the diagnostic value and patient acceptance of CTC. In
parallel with the development of limited bowel preparation
strategies, (ultra) low-dose protocols have been evaluated
[13–15].
To our knowledge, to date no studies have evaluated the
effect of dose reduction on sensitivity and specificity in
patients with a limited bowel preparation. Only one study
[7] has evaluated limited bowel preparation at a relatively
low dose level (140 kVp, 10 mAs). This study has shown
very good results; however, these data have not been
reproduced yet. Moreover, as only one dose-level was
studied, the effect of dose reduction remains unknown.
The purpose of this study was to evaluate limited bowel-
preparation CTC using an oral contrast agent (amidotrizoic
acid) in terms of image quality, patient acceptance and
polyp visualization using conventional colonoscopy (CC)
as a reference standard. A second objective was to
determine the effect of substantially reducing the radiation
dose levels on the diagnostic accuracy of limited bowel
preparation CTC, again using CC as the reference standard.
Materials and methods
Study population
PatientsoftheOnzeLieveVrouweGasthuisatincreasedrisk
forcolorectalcancer(personalorfamilyhistoryofcolorectal
polyps or cancer) [16] who were scheduled to undergo CC
between April 2002 and August 2003 were invited to
participateinthestudy.Exclusioncriteriawere:impossibility
to understand the information/informed consent, age below
18 years, pregnancy and inflammatory bowel disease. The
study was approved by the institutional review board of the
OnzeLieveVrouweGasthuisandAcademicMedicalCenter.
All patients gave written informed consent.
CTC bowel preparation and scanning protocol
Four weeks prior to the CC patients were asked to ingest
amidotrizoic acid (20 mg/ml, made by the hospital
pharmacy, 11.7 mg I/ml; corresponding to approximately
30 times diluted Gastrografin370®) three times a day
(100 ml at breakfast and lunch, 300 ml at dinner) with a
low-fiber diet (well cooked vegetables and meat, no fibrous
fruit,nowhole-wheat products,nonuts)starting2days prior
to CTC. Lactulose (12 g, lactulose CF powder 6 g/sachet,
Centrafarm, Etten-Leur, The Netherlands) was taken in the
morning for 3 days prior to CTC for stool softening. Twenty
mg of butylscopolaminebromide (Buscopan; Boehringer-
Ingelheim, Ingelheim, Germany), when contraindicated,
1 mg of glucagon hydrochloride (Glucagen; Novo-Nordisk,
Bagsvaerd, Denmark) was administered intravenously. The
colon was insufflated with a CO2-air mixture (13.2% vol.)
using a flexible catheter until patients experienced discom-
fort (±2–3 l). Patients were scanned in prone and supine
positionwithafour-sliceMX8000(PhilipsMedicalSystems,
Best, The Netherlands) CT scanner (120 kV, rotation time
0.75 s, pitch 1.25, collimation 4*2.5 mm, section thickness
3.2 mm, and reconstruction interval 1.6 mm, 50 or 70
milliampere-second (mAs); 70 mAs if the abdominal
circumference was >102.5 cm, scan time 20–25 s).
Colonoscopy
Prior to CC, each patient was instructed to ingest 4 l of a
macrogol solution (Colofort macrogol 4000 sachets, Ipsen,
Hoofddorp, The Netherlands), starting on the evening prior
to the CC. CC was performed by one of three experienced
gastroenterologists of the Onze Lieve Vrouwe Gasthuis
(experience as gastroenterologist: 23, 12 and 4 years) and
recorded on videotape. Patients received sedatives [5 mg
midazolam (Dormicum; Roche, Basel, Switzerland)] and
analgesics [0.05 mg fentanyl (Janssen Pharmaceuticals,
Beerse,Belgium)]attherequestofthepatient.Ifpolypswere
present, the locationwas determined and size was estimated,
based on comparison with an open biopsy forceps prior to
removal. A polyp was considered flat if its height was less
than one-half of the diameter of the lesion [17]. Only
segments visualized at CC were used for analysis.
Simulation of low-dose CT colonography
To study polyp detection at lower dose, CTC examinations
were simulated with a lower dose/mAs-value using an
established simulation technique [18, 19] that has been
applied in two earlier CTC studies [13, 14]. This simulation
methodconsistsofthecontrolledincreaseofnoiseintheraw
CTtransmissiondatapriortoreconstructionoftheimages.In
this way, scans were simulated at 20 mAs (in the order of
2.3 mSv for two scans: supine and prone) and 6 mAs
(±0.7 mSv). A previous simulation study has demonstrated
that the radiation dose of CTC after extensive bowel
cleansing can be reduced down to 0.2 mSv [13]. Since the
contrast between tissue and tagged fecal material in limited
bowel preparation colons is lower than that between air and
tissue, wechose 0.7mSv asthe lowest simulated dose-level
next to 2.3 mSv.
CTC evaluation
An unblinded research fellow (J.F., experience: evaluated
300 CTC) matched findings at CC (polyps ≥6 mm and
colorectal cancer) with the CTC data to provide a frame of
3113reference for true positive findings at CTC. Only exact
matches in shape, size and location were scored as a
positive match. All images were then independently
evaluated using a primary 2D display mode by three
blinded observers. The first observer (research fellow, R.v.
G., experience: compared >300 CTCs with CC videos)
evaluated the original CTC scan for image quality and for
polyps. Scores were assigned (per patient/segment,
Table 1) for overall image quality, luminal distension,
homogeneity and presence of stool. The second observer
evaluated the original CTC for polyps and marked those
examinations that were not diagnostic. If both observers
rated a CTC as not diagnostic, this patient was excluded
from analysis. The third observer first evaluated the
simulated 0.7 mSv scans for presence of polyps at least 4
weeks after the simulated 2.3 mSv scans, and again at least
4 weeks later the original CTC scans. All lesions were
measured and screenshots were taken. The second observer
(V.v.d.H., experience: 8 years of clinical CT experience as
abdominal radiologist) and the third observer (A.v.R., a
research fellow in radiology with no prior experience with
CTC) had had a learning curve in evaluating 50 CTCs with
CC feedback.
Polyp detection and image quality
A polyp detected at CTC was labeled as true positive if
three criteria were met: segmental location and location
within the segment corresponded with CC (when situated
near the borders of the segment, localization in the adjacent
segment was also accepted), the polyp size as estimated by
the endoscopist (open forceps) corresponded with size as
measured on CTC (50% margin based on the CC size was
allowed), and appearance (morphology) closely resembled
that of the corresponding polyp at videotaped CC. The
unblinded research fellow determined the nature of false-
positive findings ≥10 mm by reviewing the videotaped CC
and CTC. If the polyp was possibly missed at CC, a repeat
CC was called for.
Patient questionnaires
Patient experience and preference were evaluated by six
questionnaires (scales are shown in Table 1): 2 weeks prior
to the CTC, directly after the CTC bowel preparation, after
the CTC, after the CC preparation, after the CC and
5 weeks later. The first and the last questionnaires were sent
by mail. After the CTC bowel preparation, patients were
asked how burdensome they rated the CTC bowel prep-
aration, and the most burdensome aspect. After CTC they
rated how much pain they had experienced and how
burdensome the CTC had been. Prior to CC patients were
asked how burdensome the extensive bowel preparation
had been. After the CC they were asked how much pain
they had experienced and how burdensome the CC had
been. After the CC and 5 weeks later, patients were asked
for their preference for either CTC or CC assuming that
both techniques were equally accurate, while in 20% of
CTC examinations clinically relevant lesions would be
shown, necessitating a therapeutic CC. Two weeks prior to
the CTC, directly after the CC and 5 weeks later, patients
were asked what they were most reluctant to undergo.
Table 1 Scales used by observer 1 to rate image quality (upper part) and scales used by the patients to rate experience and preference
Observer 1: Scale
Image quality (patient, segment)* 1: poor, not diagnostic; 2: moderate, diagnostic with limitations; 3: good, diagnostic with minor
limitations; 4: excellent, no limitations
Distension (segment) 1: collapsed; 2: poorly distended; 3: only moderately distended but segment is distended over its
full length; 4: good; 5: very good
Homogeneity (segment) 1: poor; 2: moderate; 3: good; 4: very good
Presence of stool (segmemt) 1: large amount of stool, segment fully filled; 2: moderate amount of stool, ~50% of lumen filled;
3: small amount of stool; 4: only contrast layer on the wall; 5: no stool at all
Patients:
Most burdensome aspect CTC preparation: diet, lactulose, contrast agent
CTC: iv puncture, catheter placing, insufflation, breathholds, prone position
CC: iv puncture, moving of scope, air insufflation, monitoring after CC
How burdensome/painful Not, mild, moderate, severe, extreme
Preference Definitely CTC, probably CTC, possibly CTC, indifferent, possibly CC, probably CC, definitely CC
Most reluctant factor CC, bowel preparation prior to the CC, CTC, the limited bowel preparation prior to the CTC
*The items were scored per patient and per segment.
3114Statistical analysis
Differences in quality between CTC images of different
segments were assessed using ordinal regression analysis.
For this analysis we first determined the best segment and
used this segment as reference segment. The regression
coefficient of each segment estimates the change in the log
transformed diagnostic odds ratio (DOR) compared to the
reference segment. It can be interpreted, after antilogarithm
transformation as relative diagnostic odds ratio (RDOR). A
lower RDOR implies inferior image quality of the
respective segment compared to the reference segment.
Differences in polyp detection rates between CC and lower
dose CTC were assessed with the McNemar test for paired
proportions. The Wilcoxon signed rank test statistic was
used to evaluate differences in patient experience between
CTC and CC and to evaluate differences in preference
between the questionnaire filled out directly after the
procedures and 5 weeks later. The data were first
dichotomized as preference for CTC versus preference
for CC. These differences were tested using the chi-square
test statistic. All P-values <0.05 were considered to
indicate statistical significance.
Results
Sixty-three eligible patients (53%) gave written informed
consent. Two patients were excluded. One patient was
excluded since he did not undergo CC for unknown
reasons. In another patient with a 20-mm carcinoma
opposite the ileocecal valve at CC, the CTC was rated as of
no diagnostic value by both observers (parts of the large
bowel not in the field of view, stool not tagged sufficiently,
and breathing movement artifacts). Therefore, 61 patients
were analyzed (Table 2); 51 of these 61 patients could be
reviewed regarding dose reduction.
In five patients it was not possible to fully inspect the
colon endoscopically. In one patient a 14-mm polyp was
seen at CTC in a segment not inspected at CC and
confirmed at surgery (not included in the analysis). In two
patients, repeat CC showed a 30-mm polyp and a 30-mm
carcinoma (included in the analyses), both missed at the
initial CC.
Image quality
Overall image quality was rated as excellent in 2 patients,
good in 41 and moderate in 18. One patient who received a
score of poor/not diagnostic was excluded. Image quality
was significantly lower (Fig. 1) in the cecum (both
positions), sigmoid (prone position) and rectum (supine
position). This was mainly due to inferior homogeneity in
the cecum and rectum and inferior distension in the
sigmoid and rectum.
Diagnostic value
Including the findings at repeat CC, 12 patients had 15
polyps ≥10 mm (including 2 carcinomas of 35 mm and
30 mm) while 20 patients had in total 28 polyps ≥6m m
(Fig. 2). Twenty-three of 61 patients did not have any
polyps at colonoscopy. The initial CC detected 13 of the 15
large polyps (sensitivity 87%). The per-patient sensitivity
for the initial CC was 92% (11/12). The unblinded research
fellow was able to match 13/15 (87%) large polyps (in
10/12 patients: 83%), while 2 large flat lesions were not
visible in retrospect. For polyps ≥6 mm he matched 23/28
(87%) polyps (3 additional flat lesions not visible in a
patient with already a large flat lesion) in 18/20 (90%)
patients. Observers 1 and 2 correctly identified 10/15
(67%) and 9/15 (60%) polyps ≥10 mm, with respectively 5
and 8 false-positive lesions (Table 3). All but two were
explained as stool.
Polyp detection at lower dose-levels
In 51 of 61 patients, we were able to simulate and
reconstruct data at lower dose levels. In 10 of 61 patients
Table 2 Baseline characteristics of the study population
Included 61
Male/female 40/21
Age in years: mean±sd
† (range) 61±12
(27–81)
Indication:
H/O
† colorectal polyps 38
H/O colorectal carcinoma 9
F/H
† of colorectal polyps or cancer 14
Coexistent complains: Abdominal pain/hematochezia/
altered bowel habits
12/4/3
Colonoscopy: number of polyps/patients with polyps:
Any size 94/38
≥6 mm 28/20
≥10 mm 15/12
≥10 mm initial colonoscopy 13/11
Morphology of polyps ≥6 mm (sessile/stalked/flat/CRC) 12/7/7/2
Morphology of polyps ≥10 mm (sessile/stalked/flat/CRC) 3/6/4/2
Colonoscopy: no. of patients receiving Sed+analg/sed/
analg/none
29/7/3/22
Stool consistency prior to CTC (diarrhea/soft/normal) 15/13/33
Abdominal pain prior to CTC (major/minor) 1/7
Flatulence prior to CTC (major/minor) 3/27
Spasmolitycs during CTC (Buscopan/Glucagon/neither) 47/12/2
†sd: standard deviation; H/O: history of; F/H: family history, sed:
sedatives. Analg: analgesics
3115this was not possible due to missing original raw data. Dose
reduction down to 0.7 mSv was not associated with
significant changes in diagnostic value for patients with
lesions ≥10 mm (Table 4, Figs. 3 and 4). Only focusing on
the data of these 51 patients, reader 3 showed diagnostic
values comparable to or even better than reviewer 1 and 2:
sensitivity for reviewer 1 and 2 both 5 out of 10 large
polyps with respectively 5 and 8 false-positive lesions
≥10 mm and respectively 10 and 9 out of 20 polyps ≥6m m
with respectively 20 and 25 false-positives ≥6 mm. Spec-
ificity for patients without lesions ≥6 mm was significantly
lower (P=0.003) at 6 mAs when compared to the original
dose.
Patient experience and preference
The 6 questionnaires were filled out by respectively 58
(95%), 61 (100%), 61 (100%), 56 (92%), 57 (93%) and 57
(93%) patients. Two weeks prior to the CTC patients were
most reluctant to undergo CC, then the CC bowel
preparation, thirdly the limited CTC bowel preparation.
The CTC was feared least. After both procedures (fifth
questionnaire), the order was the same. Five weeks later the
bowel preparation prior to the CC was regarded to be the
most burdensome, followed by the CC, then the CTC
preparation and the CTC. None of the three aspects of the
bowel preparation for CTC (the diet, lactulose and contrast
agent) was rated significantly worse than the others
(Fig. 5). Patients rated the limited bowel preparation
(prior to CTC) less burdensome than the bowel preparation
prior to CC (Fig. 6, P<0.001). Patients also experienced
more pain during CC than during CTC (Fig. 6, P<0.001).
The most burdening aspect of the CTC was insufflation of
air (58%). The most burdening aspect of CC was the
movement of the scope (59%). Directly after the CC (fifth
questionnaire) 80% (43/54) of the patients preferred CTC
for their next examination, 13% (7) preferred CC
(P<0.001) and 7% (4) were indifferent (Fig. 6). Five
weeks after the procedures, 71% (39/55) preferred CTC,
13% (7) preferred CC (P<0.001) and 18% (10) were
indifferent. After 5 weeks there was no change (P=0.12) in
preference of CTC as the next screening test.
Discussion
This study demonstrates that CT colonography without
cleansing is preferred to colonoscopy and shows moderate
Fig. 1 Figure showing RDOR
with confidence intervals of all
six segments of the colorectum
in both prone and supine posi-
tion regarding overall image
quality, distension, presence of
stool and homogeneity. All seg-
ments are compared to the best
segment (DOR by definition 1).
Confidence intervals not reach-
ing 1 indicate significantly in-
ferior results
3116sensitivity (60–67%) for polyps ≥10 mm without impaired
diagnostic value at mSv levels as low as 0.7 mSv.
Image quality was good on average. Nevertheless, the
cecum, sigmoid and rectum showed overall reduced image
quality. Although this can be caused by the pelvis causing
more noise, reduced imaged quality must probably be
attributed to inferior homogeneity in the cecum and rectum
and inferior distension in the sigmoid and rectum in the
prone position. In contrast to the known problems in CTC
with distension, which are solved by dual positioning,
inferior homogeneity in the cecum and rectum are typical
for the limited bowel preparation protocol. Insufficient
homogeneity in the cecum is probably caused by the fact
that patients ate food after the last amount of contrast agent
was taken, resulting in inadequately tagged stool. The
inhomogeneous stool in the rectum probably was caused
by the fact that in patients with a long transit time stool was
already shaped before the fecal tagging was started.
We assume that two adaptations are necessary to
improve image quality. First, contrast must be taken as
long as the patients are eating. Second, stool should be
made softer, for example by replacing lactulose by a
stronger osmotic laxative (e.g., low-dose magnesium salts),
thereby also reducing the transit time and reducing the
amount of non-tagged stool in the rectum. Although these
adaptations increase the burden of the bowel preparation,
they are slight and are required to improve image quality
and thereby maybe the sensitivity and specificity.
Table 3 Performance characteristics per observer per size category
Variable Polyps ≥10 mm Polyps ≥6m m
Observer: Observer:
1212
Analysis according to polyp
Sensitivity 10/15 (67%) 9/15 (60%) 17/28 (61%) 15/28 (54%)
FP 5 8 20 28
PPV 10/16 (63%) 9/17 (53%) 17/38 (45%) 15/43 (35%)
Analysis according to patient
Sensitivity 8/12 (67%) 8/12 (67%) 13/20 (65%) 13/20 (65%)
Specificity 45/49 (92%) 41/49 (84%) 30/41 (73%) 25/41 (73%)
PPV 8/12 (67%) 8/16 (50%) 13/24 (54%) 13/29 (45%)
NPV 45/49 (92%) 41/45 (91%) 30/37 (81%) 25/32 (78%)
PPV: positive predictive value; NPV: negative predictive value; FP: false positives; CI: confidence interval
Fig. 2 A 76-year-old woman
with a 7-mm stalked polyp
(arrow) submerged in a layer of
tagged stool at CTC (original
dose; a: supine position, b prone
position) and at colonoscopy (c)
3117Fig. 3 Figure showing a large
12-mm false-positive lesion
(arrow) in the transverse colon
at three different dose levels in a
65-year-old male patient (a:
0.7 mSv, b: 2.3 mSv, c: origi-
nal). At lower dose levels it is
more difficult to differentiate
this lesion from a true-positive
lesion (polyp) when fecal mate-
rial is insufficiently tagged, this
especially applied to smaller
lesions. Well-tagged material is
clearly differentiated from colon
wall, even at 0.7 mSv
(arrowhead)
Table 4 Performance characteristics of observer 3 per dose level
Variable Polyps ≥10 mm Polyps ≥6m m
Dose level Dose level
Original 2.3 mSv 0.7 mSv Original 2.3 mSv 0.7 mSv
Analysis according to polyp
Sensitivity 5/10 (50%) 7/10 (70%) 4 /10 (40%) 11/20 (55%) 13/20 (65%) 10/20 (50%)
F P 22451 1 2 0
Analysis according to patient
Sensitivity 5/9 (56%) 7/9 (78%) 4 /9 (44%) 10/15 (67%) 12/15 (60%) 9/15 (45%)
Specificity 40/42 (95%) 40/42 (95%) 39/42 (93%) 33/36 (92%) 26/36 (72%) 23/36
SS (64%)
SS: statistically significant. FP: false positives
Statistical analysis (only performed on the per patient data) showed that only the specificity for patients without lesions ≥6 mm was
significantly lower (P=0.003) at 0.7 mSv when compared to the original dose
3118Our study showed an average sensitivity of 63% for
large polyps (with a limited number of large false-positive
lesions). This is lower than the 100% average sensitivity
described by Iannaccone et al. [7] using a more or less
comparable bowel preparation; no fiber-rich food and
200 ml of 370 mg/ml iodinated contrast agent in 48 h
(which is 6.3 times the amount given in our study), but no
lactulose. In addition to the differences in bowel prepara-
tion, differences in experience of the readers or reader
performance, difference in study groups (polyp prevalence
and spectrum) might explain these discrepant results. A
recent study [20] has shown inferior results regarding
diagnostic value of CTC in populations at increased risk, as
is used in the current study, possibly due to a relatively high
number of hard-to-see polyps. When comparing our study
with three large studies on CTC with extensive bowel
preparation [21–23] (showing per polyp sensitivities of
respectively 52%, 32–73% and 53% for polyps ≥10 mm),
our results are comparable or slightly better.
Since two offive (observer 1) and two of six (observer 2)
missed polyps were not seen in retrospect by the unblinded
observer, the problem of missing large polyps can be
regarded as predominantly an interpretation problem rather
than a visualization problem. Future developments, such as
better homogeneity, better distension, better learning curve,
intuitive display modes, electronic cleansing and compu-
ter-aided detection can help in reducing the number of
missed polyps.
Sensitivity and specificity were impaired at lower dose
levels for patients with lesions ≥10 mm. This is especially
of interest in screening protocols. Regarding lesions
≥6 mm, specificity was significantly lower at the simulated
0.7 mSv low-dose scans. Increased noise levels made it
impossible to see the tiny air bubbles inside stool. These
results may seem to be in contrast with those in an earlier
report on low radiation dose CTC [13] showing fewer
false-positive lesions. However, these studies in patients
with extensively cleansed colons used a three-dimensional
display mode and filters to smooth the bowel wall. By
using these smoothing filters, small artifacts and small
amounts of residual stool were masked when evaluating the
colon three dimensionally. Making stool softer and scan-
ning with thinner slices possibly allows for better visual-
ization of the air bubbles, thereby reducing the number of
false positives.
Patient acceptance was found to be very good in the
current study. Patient preference was convincingly in favor
of CTC; 71% of patients preferred CTC with limited bowel
preparation to CC for their next examination. Other studies
have shown discrepant results on patient acceptance of
CTC versus CC, some favoring CTC [24–27], others CC
[28, 29]. In a study where patients first underwent
extensive cleansing and consecutively CTC and CC [24]
fewer patients (71% directly after the CC) favored CTC
when compared to our study (80% directly after CC). This
difference cannot be attributed to the bowel preparation
because of a different study setup.
Several potential limitations must be considered. The
number of patients included is relatively low, especially for
determining the detection parameters at the 2.3 and
0.7 mSv levels.
Fig. 5 Graph showing how patients rated the three different
components of CTC with limited bowel preparation. How burden-
some were the diet, lactulose and the contrast agent?
Fig. 4 Figure showing a large
10-mm stalked polyp (arrow-
head) in the sigmoid at three
different dose levels in a 57-
year-old male patient (a:
0.7 mSv, b: 2.3 mSv, c: original)
3119In the current study no segmental unblinding during CC
was performed. Although repeat CC showed that two large
false-positive lesions were missed at the initial CC,
segmental unblinding has the advantage of evaluating all
false positives.
Since no electronic cleansing was used and many polyps
were submerged, 3D evaluation of these lesions was not of
additive value. However, 3D evaluation with electronic
cleansing might have given better results, especially since
most missed polyps were visible in retrospect.
Although the two readers that had no previous experi-
ence in CTC underwent a learning curve of 50 patients,
some studies have shown that this may not be sufficient for
optimal polyp detection [30, 31]. For CTC using limited
bowel preparation, the learning curve is possibly even
longer.
When filling out the questionnaires, sensitivity for CC
and CTC were assumed equal. If patients knew that the
sensitivity of CTC was lower than for CC, this most likely
would have influenced the preference for CTC negatively.
In conclusion, these results show that CTC with the
limited bowel preparation protocol used in this study is
feasible, even when using doses as low as 0.7 mSv levels.
Although sensitivity was not as high as previously
reported, this is most likely not due to the limited bowel
preparation, but to interpretation problems. Technical
developments will probably increase the sensitivity, while
minor adjustments in bowel preparation may reduce the
number of false positives, especially when using low-dose
protocols. Since patient acceptance was very good, this
technique can be regarded as promising in screening
patients of populations with a low prevalence of polyps.
Fig. 6 Graphs show patients’
experience of the bowel prepa-
ration (upper left) and the CTC
examination (upper right) and
patient preference for one of the
two modalities (CTC with lim-
ited bowel preparation versus
CTC with standard bowel
preparation, lower). How bur-
densome was the limited bowel
preparation prior to CTC (grey)
as compared to cleansing prior
to CC (black)? How burden-
some were the CTC (grey) and
CC (black) examinations (upper
right graphs)? What did partici-
pants prefer for their next ex-
amination (lower graph) directly
after both examinations and in
the questionnaire sent at home
5 weeks later?
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